Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Fred Hutchinson Cancer Research Center
ClinicalTrials.gov Identifier:
NCT01475058
First received: November 10, 2011
Last updated: August 4, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)